Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers

This study has been completed.

Sponsor:

Collaborators:

Genentech, Inc.

Novartis

Information provided by (Responsible Party):

H. Lee Moffitt Cancer Center and Research Institute

ClinicalTrials.gov Identifier:

NCT00738751

First received: August 18, 2008

Last updated: February 3, 2015

Last verified: February 2015

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	February 2015
Primary Completion Date:	August 2013 (Final data collection date for primary outcome measure)